Tenofovir is a nucleotide analogue reverse transcriptase inhibitor (NtRTI) primarily used in the clinical management of HIV-1 infection and chronic hepatitis B. Within this catalogue, the collection of… Read more















































Tenofovir is a nucleotide analogue reverse transcriptase inhibitor (NtRTI) primarily used in the clinical management of HIV-1 infection and chronic hepatitis B. Within this catalogue, the collection of Tenofovir reference standards, metabolites, and degradation products serves as a critical resource for pharmaceutical laboratories conducting rigorous analytical testing. These materials are essential for impurity profiling, allowing researchers to accurately identify and quantify process-related impurities and degradation products that may arise during drug substance synthesis or long-term stability studies. Furthermore, the inclusion of stable isotope labelled compounds provides precise internal standards for mass spectrometry-based assays, ensuring reliability during method validation and quality control procedures. By utilizing these characterized materials, analytical teams can maintain compliance with global regulatory frameworks, optimize sensitive analytical methods, and ensure the consistent quality of antiviral drug products throughout every stage of the pharmaceutical development and batch release process.